EUVIMEDScopri EUVIMED
Open access · CC BY-NC-ND 4.0

A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease

Anke Beermann iD, Ophélie Clottu, Marcus Reif, Ulrike Biegel, Lucia Unger iD, Christoph Koch iD

Journal of Veterinary Internal Medicine · 2024

DOI: 10.1111/jvim.17052 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Anke Beermann and 5 co-authors. Institution: Research Institute of Organic Agriculture (FiBL), Department of Livestock Sciences, Frick, Switzerland. Major MEDLINE topics: Horse Diseases, Plant Extracts. Cited 5 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: The Society of Cancer Research, Arlesheim, Switzerland, The Veterinary Association of the Canton of Neuchâtel, Neuchâtel, Switzerland, The Swiss Veterinary Association for Alternative and Complementary Medicine (camvet.ch), Bern, Switzerland.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Equine sarcoids (ES) are the most common cutaneous tumors in equids. Systemic treatment options are sparse. Subcutaneous (SC) injections of Viscum album extract (VAE) demonstrate efficacy as a systemic treatment directed against ES. Objectives/Aim To critically assess the therapeutic efficacy of orally administered VAE. Animals Forty-five ES-affected, privately owned, 3–12 year-old horses.

Methods

A 3-armed randomized placebo-controlled, double-blinded study was conducted in a double-dummy design. Horses were subjected to oral administration and SC injections of either VAE or placebo (VAE oral/placebo SC, VAE SC/placebo oral, placebo oral/placebo SC) over a 7-month treatment period. Primary endpoint was the change of baseline of a composite index of ES number and ES area after 14 months. Second endpoint was the clinical response.

Results

No statistically significant difference in the composite endpoint between the 3 study arms was found. The primary endpoint showed 4 (27%) horses in the VAE oral group with complete ES regression, 3 (21%) in the VAE SC injection group, and 2 (13%) in the placebo group. The clinical response revealed complete or partial regression in 6 horses of the oral VAE group (40%), 4 of the SC injection group (29%), and 4 of the placebo group (25%). Direct comparison of oral VAE and placebo showed an odds ratio, stratified for prognosis of 2.16 (95%-CI: 0.45–10.42) and a P-value of 0.336. Conclusion and Clinical Importance Oral administration of VAE is well tolerated. No statistically significant difference in the effectiveness of systemic VAE versus placebo against ES was found.

Subjects

MeSH terms (MEDLINE)

Horse DiseasesPlant ExtractsAnimalsHorsesAdministration, OralInjections, SubcutaneousDouble-Blind MethodFemaleMaleSkin NeoplasmsSarcoidosisViscum album

Author keywords

Viscum album extractequine sarcoidhorseimmunotherapymistletoerandomized trial

Substances

Plant Extracts

Authors and institutions

  • Research Institute of Organic Agriculture (FiBL), Department of Livestock Sciences, Frick, Switzerland.
  • Society of Clinical Research e.V, Berlin, Germany.
  • Department of Clinical Veterinary Medicine, Swiss Institute of Equine Medicine (ISME), University of Bern, Bern, Switzerland.

ORCID profiles: Anke Beermann, Lucia Unger, Christoph Koch

Funding

  • The Society of Cancer Research, Arlesheim, Switzerland
  • The Veterinary Association of the Canton of Neuchâtel, Neuchâtel, Switzerland
  • The Swiss Veterinary Association for Alternative and Complementary Medicine (camvet.ch), Bern, Switzerland
  • The Rudolf Steiner Fund for Scientific Research e.V., Nuremberg, Germany

Cite

APA

Beermann, A., Clottu, O., Reif, M., Biegel, U., Unger, L., & Koch, C. (2024). A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17052

Vancouver

Beermann A, Clottu O, Reif M, Biegel U, Unger L, Koch C. A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.17052

BibTeX
@article{Beermann2024,
  author = {Beermann, Anke and Clottu, Ophélie and Reif, Marcus and Biegel, Ulrike and Unger, Lucia and Koch, Christoph},
  title = {A randomized placebo-controlled double-blinded study comparing oral and subcutaneous administration of mistletoe extract for the treatment of equine sarcoid disease},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2024},
  doi = {10.1111/jvim.17052}
}
Start for free →